Sepsis Stewardship: The Puzzle of Antibiotic Therapy in the Context of Individualization of Decision Making

被引:3
作者
Ramasco, Fernando [1 ]
Mendez, Rosa [1 ]
de la Rica, Alejandro Suarez [1 ]
de Castro, Rafael Gonzalez [2 ]
Maseda, Emilio [3 ]
机构
[1] Hosp Univ La Princesa, Dept Anaesthesiol & Surg Intens Care, Diego Leon 62, Madrid 28006, Spain
[2] Univ Hosp Leon, Dept Rheumatol, Leon 24071, Spain
[3] Hosp Univ Fdn Alcorcon, Dept Traumatol & Orthopaed Surg, Madrid, Spain
来源
JOURNAL OF PERSONALIZED MEDICINE | 2024年 / 14卷 / 01期
关键词
Antimicrobial Stewardship; sparing carbapenems; new antibiotics; antimicrobial resistance; individualization; antibiotic treatment; sepsis; septic shock; Gram negatives; VENTILATOR-ASSOCIATED PNEUMONIA; INFECTIOUS-DISEASES SOCIETY; INTENSIVE-CARE-UNIT; BETA-LACTAM ANTIBIOTICS; CRITICALLY-ILL PATIENTS; ANTIMICROBIAL THERAPY; SEPTIC SHOCK; CLINICAL MICROBIOLOGY; AMERICAN-COLLEGE; EUROPEAN-SOCIETY;
D O I
10.3390/jpm14010106
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The main recent change observed in the field of critical patient infection has been universal awareness of the need to make better use of antimicrobials, especially for the most serious cases, beyond the application of simple and effective formulas or rigid protocols. The increase in resistant microorganisms, the quantitative increase in major surgeries and interventional procedures in the highest risk patients, and the appearance of a significant number of new antibiotics in recent years (some very specifically directed against certain mechanisms of resistance and others with a broader spectrum of applications) have led us to shift our questions from "what to deal with" to "how to treat". There has been controversy about how best to approach antibiotic treatment of complex cases of sepsis. The individualized and adjusted dosage, the moment of its administration, the objective, and the selection of the regimen are pointed out as factors of special relevance in a critically ill patient where the frequency of resistant microorganisms, especially among the Enterobacterales group, and the emergence of multiple and diverse antibiotic treatment alternatives have made the appropriate choice of antibiotic treatment more complex, requiring a constant updating of knowledge and the creation of multidisciplinary teams to confront new infections that are difficult to treat. In this article, we have reviewed the phenomenon of the emergence of resistance to antibacterials and we have tried to share some of the ideas, such as stewardship, sparing carbapenems, and organizational, microbiological, pharmacological, and knowledge tools, that we have considered most useful and effective for individualized decision making that takes into account the current context of multidrug resistance. The greatest challenge, therefore, of decision making in this context lies in determining an effective, optimal, and balanced empirical antibiotic treatment.
引用
收藏
页数:37
相关论文
共 167 条
  • [91] Sepsis and the Microbiome: A Vicious Cycle
    Miller, William D.
    Keskey, Robert
    Alverdy, John C.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2021, 223 : S264 - S269
  • [92] Therapeutic management of peritonitis: a comprehensive guide for intensivists
    Montravers, P.
    Blot, S.
    Dimopoulos, G.
    Eckmann, C.
    Eggimann, P.
    Guirao, X.
    Paiva, J. A.
    Sganga, G.
    De Waele, J.
    [J]. INTENSIVE CARE MEDICINE, 2016, 42 (08) : 1234 - 1247
  • [93] Montravers P, 2018, CURR OPIN INFECT DIS, V31, P587, DOI [10.1097/QCO.0000000000000490, 10.1097/qco.0000000000000490]
  • [94] Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial
    Montravers, Philippe
    Tubach, Florence
    Lescot, Thomas
    Veber, Benoit
    Esposito-Farese, Marina
    Seguin, Philippe
    Paugam, Catherine
    Lepape, Alain
    Meistelman, Claude
    Cousson, Joel
    Tesniere, Antoine
    Plantefeve, Gaetan
    Blasco, Gilles
    Asehnoune, Karim
    Jaber, Samir
    Lasocki, Sigismond
    Dupont, Herve
    [J]. INTENSIVE CARE MEDICINE, 2018, 44 (03) : 300 - 310
  • [95] Surveillance of Resistance to New Antibiotics in an Era of Limited Treatment Options
    Morel, Chantal M.
    de Kraker, Marlieke E. A.
    Harbarth, Stephan
    [J]. FRONTIERS IN MEDICINE, 2021, 8
  • [96] Rubio EM, 2019, REV ESP QUIM, V32, P62
  • [97] New definitions of susceptibility categories EUCAST 2019: clinic application
    Nabal Diaz, Sandra G.
    Algara Robles, Olga
    Garcia-Lechuz Moya, Juan M.
    [J]. REVISTA ESPANOLA DE QUIMIOTERAPIA, 2022, 35 : 84 - 88
  • [98] Initial antimicrobial management of sepsis
    Niederman, Michael S.
    Baron, Rebecca M.
    Bouadma, Lila
    Calandra, Thierry
    Daneman, Nick
    DeWaele, Jan
    Kollef, Marin H.
    Lipman, Jeffrey
    Nair, Girish B.
    [J]. CRITICAL CARE, 2021, 25 (01)
  • [99] The Need of Antimicrobial Stewardship in Post-Operative Infectious Complications of Abdominal Surgery
    Obst, Wilfried
    Esser, Torben
    Kaasch, Achim Jens
    Geginat, Gernot
    Meyer, Frank
    Croner, Roland S.
    Keitel, Verena
    [J]. VISCERAL MEDICINE, 2022, 38 (05) : 345 - 353
  • [100] Ordoñez Carlos A., 2021, Colomb. Med., V52, pe4194809, DOI 10.25100/cm.v52i2.4809